Treating Seizure Clusters in the Outpatient Setting
Seizure clusters have been associated with a high rate of hospital admissions, and if left untreated, there is an increased risk of developing status epilepticus, seizure-related injuries, higher mortality rates and an
increased risk of postictal psychosis.
Midazolam nasal spray (MDZ-NS) is a portable and easy to use drug-device for the treatment of seizure clusters in the outpatient setting that does not require administration by a healthcare provider. It is also more socially acceptable than rectally administered therapies.
